Načítá se...
Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-β2
Glypican 3 (GPC3) is a valuable diagnostic marker and a potential therapeutic target in hepatocellular carcinoma (HCC). To evaluate the efficacy of targeting GPC3 at the translational level, we used RNA interference to examine the biologic and molecular effects of GPC3 suppression in HCC cells in vi...
Uloženo v:
Hlavní autoři: | , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Neoplasia Press Inc.
2011
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3156664/ https://ncbi.nlm.nih.gov/pubmed/21847365 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|